OTCs Launched On Fluticasone ANDAs, Lidocaine In Monograph
Executive Summary
Innovus entering OTC fluticasone market in November; and Rising Biosciences prepares topical OTC pain relief.
You may also be interested in...
OTC, Supplement Co-Packaging Potential Could Be Clipped By FDA Proposed Rule
Innovus Pharmaceuticals is among the firms offering supplements and OTC drugs sold together, an option CRN trade group encourages FDA to allow. FDA will determine on a case-by-case basis whether already available co-packaged OTCs and supplements violate a proposed rule on drug co-packaging.
Fluticasone Spray Competition Grows With Perrigo Launch Of West-Ward Product
FDA approves Hikma Pharmaceuticals subsidiary West-Ward Pharmaceuticals' ANDA for fluticasone propionate/0.05mg per spray and Perrigo is shipping the generic equivalent of Flonase Allergy Relief to retailers and distributors.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.